Compound ID | 2222
Class: Small molecule antibacterial agent
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Active against ESKAPE pathogens including arm, erm-, cfr- and lsaA-expressing strains; binds to the large ribosomal subunit interfering with translation initiation |
Description: | Synthetic compound (component based and structure guided design; contains oxepanoprolinamide core); non-haemolytic and non-toxic towards mammalian cell; bacteriostatic |
Year first mentioned: | 2021 |
Development status: | Experimental |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/162366972 |
Guide to Pharmacology: | iboxamycin |
Citations: |
|